Spots Global Cancer Trial Database for Stereotactic Volumetric Radiotherapy in Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Stereotactic Volumetric Radiotherapy in Prostate Cancer
Official Title: Stereotactic Radiotherapy in Low Risk Prostate Cancer: a Phase II Study
Study ID: NCT02423889
Conditions
Interventions
Study Description
Brief Summary: This is a prospective, single arm, phase II, multicentric study. It evaluates the acute and late toxicity after stereotactic radiotherapy in low risk prostate cancer patients. All participants receive a total dose of 36.25 Gy in 5 fractions, twice a week, 7.25 Gy per fraction.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
IRCCS AOU San Martino-IST, Genoa, GE, Italy
AO Città della salute e della scienza - Molinette, Turin, TO, Italy
Istituto del Radio "O. Alberti" Spedali Civili - University of Brescia, Brescia, , Italy
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
